September 17, 2020
Eli Lilly’s coronavirus antibody drug cut hospitalization rates by THREE-FOLD for mild or moderately ill patients, early study data reveals
The antibody, LY-CoV555, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body